Coronavirus Notebook: EU Opinion On Moderna’s mRNA-1273 Expected This Week, UK Boosts Vaccine Rollout As Lockdown Imposed
Executive Summary
UK biotech firm Emergex has signed a deal with Brazil’s Biocruz for the development of a T-cell based vaccine, and the Philippines regulator has issued a warning after reports that members of the country’s presidential guard received an unauthorized vaccine produced by China’s Sinopharm.
You may also be interested in...
EU Approval Of Oxford/AstraZeneca COVID-19 Vaccine Expected By End Of January
AstraZeneca is expected to apply for the EU approval of its COVID-19 vaccine next week. The vaccine was developed in partnership with the University of Oxford.
UK Begins Controversial 12 Week Strategy With AZ and Pfizer Vaccines
Entering a new lockdown, the UK sees its plans to space out doses of the COVID-19 vaccines to 12 weeks as crucial to overcoming the pandemic.
Hungary Breaks Ranks With EU & Authorizes Use Of AstraZeneca Vaccine
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: